These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32174243)

  • 41. A pilot study of the shapes of ablation lesions in the canine prostate by laser, radiofrequency and microwave and their clinical significance.
    Liu R; Duan S; Cao H; Cao G; Chang Z; Zhang Y; Li Y; Wu Y; Liu L; Zhang L
    PLoS One; 2020; 15(4):e0223229. PubMed ID: 32271751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
    Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of conventional US, contrast enhanced US and enhanced MR for the follow-up of prostatic radiofrequency ablation.
    Feng C; Hu B; Hu B; Chen L; Li J; Huang J
    Exp Ther Med; 2017 Jun; 13(6):3535-3542. PubMed ID: 28588677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
    Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
    Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M
    Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation.
    Guo F; Hu B; Chen L; Li J
    Br J Radiol; 2019 Nov; 92(1103):20190183. PubMed ID: 31509441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast-enhanced ultrasonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta-analysis.
    Shi W; He Y; Ding W; Gong S; Wang Y; Xiao J; He B
    Br J Radiol; 2016 Aug; 89(1064):20150973. PubMed ID: 27327401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring laparoscopic radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: an open-label, randomized, comparative pilot trial.
    Chen Y; Huang J; Xia L; Dong B; Chen W; Xue W; Liu D; Huang Y
    J Endourol; 2013 Jun; 27(6):697-704. PubMed ID: 23442174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma.
    Gallotti A; D'Onofrio M; Ruzzenente A; Martone E; De Robertis R; Guglielmi A; Pozzi Mucelli R
    Radiol Med; 2009 Oct; 114(7):1094-105. PubMed ID: 19756947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma.
    Liu Z; Wang X; Xing L; Pan Y; Huang S
    Cancer Biother Radiopharm; 2019 Dec; 34(10):621-625. PubMed ID: 31809215
    [No Abstract]   [Full Text] [Related]  

  • 54. Contrast-enhanced ultrasonography follow-up after radiofrequency ablation in normal rabbit kidney.
    Wu R; Xu FH; Yao MH; Xie J; Hu B
    Arch Med Sci; 2013 Aug; 9(4):608-13. PubMed ID: 24049518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Microwave ablation of the canine prostate: an experimental study].
    Li ZC; Zhang J; Hu DM; Wang Q; Ren JT; Lin MH
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):10-3. PubMed ID: 24527530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
    Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
    BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
    Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients.
    Zhao X; Wang W; Zhang S; Liu J; Zhang F; Ji C; Li X; Gan W; Zhang G; Guo H
    Abdom Imaging; 2012 Oct; 37(5):885-91. PubMed ID: 22131041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma.
    Wu JY; Chen MH; Yang W; Lin SZ; Wu W; Yin SS; Zhang H; Yan K
    Chin J Cancer Res; 2012 Mar; 24(1):44-51. PubMed ID: 23359761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.